Labetuzumab
CAS No. 219649-07-7
Labetuzumab
male-enhanced antigen
126729-44-0
Nickel, bis[(2,3-h)-2-propenenitrile]-
12266-58-9
PH-DTPA
126736-75-2
(4-Bromo-3-methylphenyl)(cyclopropyl)methanone
1267167-02-1
3-Bromo-2-(methylthio)-5-(trifluoromethyl)pyridine
1226808-64-5
hydroxysodalite
12267-62-8
4-ISOXAZOLAMINE,N-[(TERT-BUTYL)CARBONIMIDOYL]-
122686-19-5
ETHYL 1-(CYANOMETHYL)-1H-INDOLE-2-CARBOXYLATE
126718-04-5
Phosphonitrile amide, N,N'-diphenyl-
12673-66-4
Oxirane, 2,2-difluoro-
126716-68-5
5-[(1E)-1-butylpent-1-en-1-yl]-1,3-benzodioxole
122666-15-3
Benzoic acid, 3-nitro-4-[(2-phenylethyl)amino]-
123557-14-2
Pigment yellow 184
126729-57-5
Indium oxide
12672-71-8
SpirostaphylotrichinF
123548-49-2
反式-2-[2-(3-氯丙基)环丙基]硼酸频哪醇酯
Mo.Ni.O
12673-58-4
Phosphine, ethenylmethylene-
122682-85-3
cellulose trisphenylcarbamate
126729-54-2
4-(4-Ethoxycarbonyl)piperazino-1-bromobenzene
1226808-66-7
(-)-BlestriareneC
126721-54-8
insulin, diacetyl(A1-B29)-
12671-72-6
tungstoarsenate
12267-69-5
2-Propenyl, 1-dioxy-2-methyl-
123549-46-2
Iron, compd. with terbium (3:1)
12268-62-1
SpirostaphylotrichinM
123548-72-1
Boron(1+), difluoro-
12355-90-7
5-(1,3-benzodioxol-5-yl)nonan-5-ol
122666-14-2